Myxoid Liposarcoma
📧 Sign up to get email alerts when something new happens for Myxoid Liposarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma [Phase 1, Phase 2]
This update reports on a Phase 1/2 clinical trial evaluating the MEK inhibitor mirdametinib in combination with palbociclib for liposarcoma,…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel
Expanded Access Protocol (EAP) for nonconforming Afami-cel is available for patients with synovial sarcoma or myxoid liposarcoma.
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma [Phase 1]
This ClinicalTrials.gov update reports that a Phase 1 study of BTX-A51 is currently recruiting for liposarcoma and CIC-rearranged sarcoma, i…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma [Phase 1]
This is a Phase 1 study to evaluate the safety and tolerability of MDG1015 in patients with epithelial ovarian cancer, gastroesophageal junc…
-
CLINICAL_TRIALS research · 2010-02-26Clinical Trial Update: Brostallicin Clinical Trial for Myxoid Liposarcoma [Phase 2]
Status update on a Phase 2 trial of brostallicin for myxoid liposarcoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.